Dr Katie FineganMRPharmS

Lecturer in Cancer Biology and Therapy

Full contact details
View graph of relations

Publications

  1. 2018
  2. Published

    From Bench to Bedside: World Cancer Day Open Day Extravaganza

    Finegan, K. & Allison, D., 27 Mar 2018, In : Global Journal of Pharmacy & Pharmaceutical Sciences. 5, 2, p. 1-3 3 p.

    Research output: Contribution to journalArticle

  3. Published

    Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition

    Giurisato, E., Xu, Q., Lonardi, S., Telfer, B., Russo, I., Pearson, A., Finegan, K., Wang, W., Wang, J., Gray, N. S., Vermi, W., Xia, Z. & Tournier, C., Mar 2018, In : Proceedings of the National Academy of Sciences.

    Research output: Contribution to journalArticle

  4. 2016
  5. Published

    Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models

    O'Connor, J., Boult, J. K. R., Jamin, Y., Babur, M., Finegan, K., Williams, K., Little, R., Jackson, A., Parker, G., Reynolds, A. R., Waterton, J. & Robinson, S. P., 15 Feb 2016, In : Cancer Research. 76, 4, p. 787-795 9 p.

    Research output: Contribution to journalArticle

  6. 2015
  7. Published

    ERK5 is a critical mediator of inflammation-driven cancer.

    Finegan, K., Perez Madrigal, D., Hitchin, J., Davies, C., Jordan, A. & Tournier, C., 15 Feb 2015, In : Cancer Research. 75, 4

    Research output: Contribution to journalArticle

  8. 2014
  9. Published

    Impaired JNK signaling cooperates with KrasG12D expression to accelerate pancreatic ductal adenocarcinoma

    Mcmahon, R., Tournier, C., Davies, C. C., Harvey, E., Finegan, K. G., Connor, F., Davis, R. J., Tuveson, D. A. & Tournier, C., 15 Jun 2014, In : Cancer Research. 74, 12, p. 3344-3356 12 p.

    Research output: Contribution to journalArticle

  10. 2012
  11. Published

    The extracellular-regulated protein kinase 5 (ERK5) promotes cell proliferation through the down-regulation of inhibitors of cyclin dependent protein kinases (CDKs)

    Perez-Madrigal, D., Finegan, K. G., Paramo, B. & Tournier, C., Dec 2012, In : Cellular Signalling. 24, 12, p. 2360-2368 8 p.

    Research output: Contribution to journalArticle

  12. 2010
  13. Published

    The mitogen-activated protein kinase kinase 4 has a pro-oncogenic role in skin cancer

    Finegan, K. G. & Tournier, C., 15 Jul 2010, In : Cancer Research. 70, 14, p. 5797-5806 9 p.

    Research output: Contribution to journalArticle

  14. 2009
  15. Published

    Regulation of neuronal survival by the extracellular signal-regulated protein kinase 5

    Finegan, K. G., Wang, X., Lee, E. J., Robinson, A. C. & Tournier, C., 2009, In : Cell Death and Differentiation. 16, 5, p. 674-683 9 p.

    Research output: Contribution to journalArticle

  16. 2006
  17. Published

    Activation of extracellular signal-regulated protein kinase 5 downregulates FasL upon osmotic stress

    Wang, X., Finegan, K. G., Robinson, A. C., Knowles, L., Khosravi-Far, R., Hinchliffe, K. A., Boot-Handford, R. P. & Tournier, C., Dec 2006, In : Cell Death and Differentiation. 13, 12, p. 2099-2108 9 p.

    Research output: Contribution to journalArticle

  18. Published

    The regulation of Bax by c-Jun N-terminal protein kinase (JNK) is a prerequisite to the mitochondrial-induced apoptotic pathway

    Papadakis, E. S., Finegan, K. G., Wang, X., Robinson, A. C., Guo, C., Kayahara, M. & Tournier, C., 20 Feb 2006, In : FEBS Letters. 580, 5, p. 1320-1326 6 p.

    Research output: Contribution to journalArticle

Previous 1 2 Next

Research Explorer downloads

25

Research output: Contribution to journalArticle

18